Bronchitis Chronic
📧 Sign up to get email alerts when something new happens for Bronchitis Chronic.
Sign up freeTop drugs studied for this disease
-
EMA withdrawal · 2019-06-19EMA Withdrawn: Ketek (telithromycin) — Aventis Pharma S.A.
Telithromycin (Ketek) has been withdrawn from the European market by Aventis Pharma S.A. after regulatory assessment.
-
EMA withdrawal · 2008-02-14EMA Withdrawn: Levviax (telithromycin) — Aventis Pharma S.A.
Telithromycin (Levviax) has been withdrawn from the market by Aventis Pharma S.A. for community-acquired infections including pharyngitis, b…
-
EMA withdrawal · 2007-07-26EMA Application withdrawn: Garenoxacin mesylate — Schering-Plough Europe
The EMA application for garenoxacin mesylate by Schering-Plough Europe was withdrawn.